'Bet hedging' explains the efficacy of many combination cancer therapies

The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study.

from Top Technology News -- ScienceDaily http://ift.tt/2yuPqGx
via IFTTT
Previous
Next Post »

StatCounter